Curebase adds voice analysis capabilities to clinical trials
Curebase partners with Redenlab to be able to provide voice and language tests to be used through its decentralized trial model.
Curebase partners with Redenlab to be able to provide voice and language tests to be used through its decentralized trial model.
Metrion Biosciences has leased a new facility and added high-throughput screening (HTS) capacity to support its ion channel drug discovery projects.
CordenPharma joins global science initiative SBTi and announces commitment to ambitious reduction in greenhouse gas emissions in alignment with the Paris agreement.